Sonnet BioTherapeutics Holdings Inc XNAS: SONN

Sonnet BioTherapeutics Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Sonnet BioTherapeutics Holdings Inc: Is Infosys Ltd. worth buying?
Item: Sonnet BioTherapeutics Holdings Inc
Rating: 1.02750
Author: Trendlyne DVM scores

Download real time

1.38 -0.05 (-3.50%)

92.26% Fall from 52W High

66,899 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

20.0 / 100

Technically Bearish

21.1 / 100

160

1Yr Price target upside is 11494%

1 analysts

Sonnet BioTherapeutics Hol... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sonnet BioTherapeutics Holdings Inc FAQ

How is Sonnet BioTherapeutics Holdings Inc today?

Sonnet BioTherapeutics Holdings Inc today is trading in the red, and is down by -3.50% at 1.38.

How has Sonnet BioTherapeutics Holdings Inc performed historically?

Sonnet BioTherapeutics Holdings Inc is currently trading down -3.50% on an intraday basis. In the past week the stock rose 1.47%. stock has been down -14.81% in the past quarter and fell -91.94% in the past year. You can view this in the overview section.